192 related articles for article (PubMed ID: 22851646)
1. Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver.
Wallace MD; Pfefferle AD; Shen L; McNairn AJ; Cerami EG; Fallon BL; Rinaldi VD; Southard TL; Perou CM; Schimenti JC
Genetics; 2012 Oct; 192(2):385-96. PubMed ID: 22851646
[TBL] [Abstract][Full Text] [Related]
2. Mouse Models of Breast Cancer Share Amplification and Deletion Events with Human Breast Cancer.
Rennhack J; To B; Wermuth H; Andrechek ER
J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):71-84. PubMed ID: 28124185
[TBL] [Abstract][Full Text] [Related]
3. Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.
Annunziato S; de Ruiter JR; Henneman L; Brambillasca CS; Lutz C; Vaillant F; Ferrante F; Drenth AP; van der Burg E; Siteur B; van Gerwen B; de Bruijn R; van Miltenburg MH; Huijbers IJ; van de Ven M; Visvader JE; Lindeman GJ; Wessels LFA; Jonkers J
Nat Commun; 2019 Jan; 10(1):397. PubMed ID: 30674894
[TBL] [Abstract][Full Text] [Related]
4. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.
Herschkowitz JI; Zhao W; Zhang M; Usary J; Murrow G; Edwards D; Knezevic J; Greene SB; Darr D; Troester MA; Hilsenbeck SG; Medina D; Perou CM; Rosen JM
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2778-83. PubMed ID: 21633010
[TBL] [Abstract][Full Text] [Related]
5. Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients.
Ronowicz A; Janaszak-Jasiecka A; Skokowski J; Madanecki P; Bartoszewski R; Bałut M; Seroczyńska B; Kochan K; Bogdan A; Butkus M; Pęksa R; Ratajska M; Kuźniacka A; Wasąg B; Gucwa M; Krzyżanowski M; Jaśkiewicz J; Jankowski Z; Forsberg L; Ochocka JR; Limon J; Crowley MR; Buckley PG; Messiaen L; Dumanski JP; Piotrowski A
Hum Mutat; 2015 Nov; 36(11):1088-99. PubMed ID: 26219265
[TBL] [Abstract][Full Text] [Related]
6. Germline and Somatic
Wang X; Kallionpää RA; Gonzales PR; Chitale DA; Tousignant RN; Crowley JP; Chen Z; Yoder SJ; Blakeley JO; Acosta MT; Korf BR; Messiaen LM; Tainsky MA
Cancer Prev Res (Phila); 2018 Oct; 11(10):655-664. PubMed ID: 30104415
[No Abstract] [Full Text] [Related]
7. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations.
Sangha N; Wu R; Kuick R; Powers S; Mu D; Fiander D; Yuen K; Katabuchi H; Tashiro H; Fearon ER; Cho KR
Neoplasia; 2008 Dec; 10(12):1362-72, following 1372. PubMed ID: 19048115
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells.
Li F; Munchhof AM; White HA; Mead LE; Krier TR; Fenoglio A; Chen S; Wu X; Cai S; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1921-30. PubMed ID: 16644864
[TBL] [Abstract][Full Text] [Related]
10. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
11. Identifying the Ubiquitin Ligase complex that regulates the NF1 tumor suppressor and Ras.
Hollstein PE; Cichowski K
Cancer Discov; 2013 Aug; 3(8):880-93. PubMed ID: 23661552
[TBL] [Abstract][Full Text] [Related]
12. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
[TBL] [Abstract][Full Text] [Related]
13. Genomic Profiling in Patients With Malignant Peripheral Nerve Sheath Tumors Reveals Multiple Pathways With Targetable Mutations.
Kaplan HG; Rostad S; Ross JS; Ali SM; Millis SZ
J Natl Compr Canc Netw; 2018 Aug; 16(8):967-974. PubMed ID: 30099373
[No Abstract] [Full Text] [Related]
14. Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.
Zheng ZY; Anurag M; Lei JT; Cao J; Singh P; Peng J; Kennedy H; Nguyen NC; Chen Y; Lavere P; Li J; Du XH; Cakar B; Song W; Kim BJ; Shi J; Seker S; Chan DW; Zhao GQ; Chen X; Banks KC; Lanman RB; Shafaee MN; Zhang XH; Vasaikar S; Zhang B; Hilsenbeck SG; Li W; Foulds CE; Ellis MJ; Chang EC
Cancer Cell; 2020 Mar; 37(3):387-402.e7. PubMed ID: 32142667
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.
McPherson JR; Ong CK; Ng CC; Rajasegaran V; Heng HL; Yu WS; Tan BK; Madhukumar P; Teo MC; Ngeow J; Thike AA; Rozen SG; Tan PH; Lee AS; Teh BT; Yap YS
Cancer Med; 2015 Dec; 4(12):1871-8. PubMed ID: 26432421
[TBL] [Abstract][Full Text] [Related]
16. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
McGillicuddy LT; Fromm JA; Hollstein PE; Kubek S; Beroukhim R; De Raedt T; Johnson BW; Williams SM; Nghiemphu P; Liau LM; Cloughesy TF; Mischel PS; Parret A; Seiler J; Moldenhauer G; Scheffzek K; Stemmer-Rachamimov AO; Sawyers CL; Brennan C; Messiaen L; Mellinghoff IK; Cichowski K
Cancer Cell; 2009 Jul; 16(1):44-54. PubMed ID: 19573811
[TBL] [Abstract][Full Text] [Related]
17. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
18. Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer.
Sokol ES; Feng YX; Jin DX; Basudan A; Lee AV; Atkinson JM; Chen J; Stephens PJ; Frampton GM; Gupta PB; Ross JS; Chung JH; Oesterreich S; Ali SM; Hartmaier RJ
Ann Oncol; 2019 Jan; 30(1):115-123. PubMed ID: 30423024
[TBL] [Abstract][Full Text] [Related]
19. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.
Cichowski K; Santiago S; Jardim M; Johnson BW; Jacks T
Genes Dev; 2003 Feb; 17(4):449-54. PubMed ID: 12600938
[TBL] [Abstract][Full Text] [Related]
20. Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers.
Holstege H; van Beers E; Velds A; Liu X; Joosse SA; Klarenbeek S; Schut E; Kerkhoven R; Klijn CN; Wessels LF; Nederlof PM; Jonkers J
BMC Cancer; 2010 Aug; 10():455. PubMed ID: 20735817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
